An allosteric HTRA1-calpain 2 complex with restricted activation profile.
Juliana ReyMaike BreidenVanda LuxAnika BluemkeMaike SteindelKamilla RipkensBastian MöllersKenny Bravo RodriguezPrisca BoisguerinRudolf VolkmerJoel Mieres PerezTim ClausenElsa Sanchez-GarciaMichael EhrmannPublished in: Proceedings of the National Academy of Sciences of the United States of America (2022)
SignificanceClassic serine proteases are synthesized as inactive precursors that are proteolytically processed, resulting in irreversible activation. We report an alternative and reversible mechanism of activation that is executed by an inactive protease. This mechanism involves a protein complex between the serine protease HTRA1 and the cysteine protease calpain 2. Surprisingly, activation is restricted as it improves the proteolysis of soluble tau protein but not the dissociation and degradation of its amyloid fibrils, a task that free HTRA1 is efficiently performing. These data exemplify a challenge for protein quality control proteases in the clearing of pathogenic fibrils and suggest a potential for unexpected side effects of chemical modulators targeting PDZ or other domains located at a distance to the active site.